 CHARLOTTESVILLE, VA ACCESSWIRE February 14, 2020 Adial Pharmaceuticals, Inc. NASDAQ:ADIL;ADILW, a clinical-stage biopharmaceutical company focused on the development of treatments for addiction, is pleased to announce that the Companys CEO, William Stilley, has been selected as a luncheon keynote speaker for the 2020 Wall Street Conference and Retreat to be held in West Palm Beach, Florida on February 19-20. The Company recently announced it has commenced a Phase 3 pivotal clinical trial to investigate AD04 as a genetically targeted therapeutic agent for the treatment of Alcohol Use Disorder AUD. 